&nbsp;

PeerReviewGuidanceDocument.pdf

Dec 1969

Guidelines and Advice

Person-Centred Virtual Cancer Care Clinical Guidance

Status: Current
Version: 2

Jan 2022

Document

jonathanFoster.jpg

Jul 2021

Regimen

PRLS

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pralsetinib (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2021

Regimen

PEMB

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Adjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Adjuvant Treatment for Renal Cell Carcinoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Mar 2023

Regimen

PACL(W)+PEMB

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Recurrent Unresectable or Metastatic Triple Negative Breast Cancer

Drugs Used:

pembrolizumab,

PACLitaxel

Quick Link(s):

Regimen Monograph

Sep 2023

Document

PCC_4233_FN_CancerScreeningGuide.pdf

Nov 2021

Document

PCC_4233_FN_CancerScreeningGuide_FR.pdf

Nov 2021

Guidelines and Advice

Preoperative Breast Magnetic Resonance Imaging

Status: Current
ID: GL 1-25
Version: N/A

Mar 2023

Regimen

PEMB(MNT)

Cancer Type:

Gynecologic,

Cervix

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Metastatic, Persistent, or Recurrent Carcinoma of the Cervix

Drugs Used:

Quick Link(s):

Regimen Monograph

Regimen

PEMB

Cancer Type:

Gynecologic,

Endometrial

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Treated MSI-H/dMMR Advanced Endometrial Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

PEMB

Cancer Type:

Breast

Intent: Adjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer

Drugs Used: